Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Joel Levitan"'
Autor:
Costi Alifrangis, Biancastella Cereser, Philip Carter, Justin Stebbing, Pramodh Chandrasinghe, Neha Tabassum, Lisa Del Bel Belluz, Jinrui Wen, Joel Levitan, Jonathan Krell, Nina Moderau, Lee S. Schwartzberg, Thomas J. Herzog
Publikováno v:
Oncotarget
// Philip Carter 1 , Costi Alifrangis 2 , Biancastella Cereser 1 , Pramodh Chandrasinghe 1, 3 , Lisa Del Bel Belluz 1 , Thomas Herzog 4, 5 , Joel Levitan 1 , Nina Moderau 1 , Lee Schwartzberg 6 , Neha Tabassum 1 , Jinrui Wen 1 , Jonathan Krell 1 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc5b310cb23023217dd1c5bdc752044
https://doi.org/10.18632/oncotarget.24258
https://doi.org/10.18632/oncotarget.24258
Autor:
Justin Stebbing, Thomas J. Herzog, Neha Tabassum, Costi Alifrangis, Lee S. Schwartzberg, Jinrui Wen, Joel Levitan, Nina Moderau, Pramodh Chandrasinghe, Philip Carter, Lisa Del Bel Belluz, Biancastella Cereser, Jonathan Krell
Publikováno v:
Oncotarget
We evaluated the effect of tailoring treatments based on predictions informed by tumor molecular profiles across a range of cancers, using data from Caris Life Sciences. These included breast carcinoma, colorectal adenocarcinoma, female genital tract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33afd6c905d78b4e47a621588d257bd
http://hdl.handle.net/10044/1/59666
http://hdl.handle.net/10044/1/59666
